Hormone Therapy for Women in Beverly Hills

It depends on your age, how long since menopause, your personal and family history, and which preparation and route are used. Current understanding gives substantial weight to timing — women starting closer to menopause, generally within about ten years and under 60, tend to have a more favorable risk-benefit balance. It is not appropriate with a history of breast or other hormone-sensitive cancer, unexplained vaginal bleeding, active liver disease, or unprovoked clots. This needs to be an individual conversation.

That headline came from a large early-2000s trial and the reality is more nuanced. The study population was considerably older than women who typically begin therapy, averaging well past menopause. Later analysis showed risk varies significantly by age at initiation, preparation, route, and duration. The finding was real but it was widely over-generalized, and it led to many women being denied treatment that would have suited them.

Often yes. Perimenopause is when many women have their most disruptive symptoms, driven by erratic fluctuation rather than a steady decline. This is also why bloodwork during perimenopause can look normal — levels vary day to day. Symptoms and history matter as much as a single laboratory value in this phase.

It matters more than most people realize. Transdermal estrogen — patches and gels — bypasses first-pass liver metabolism and appears to carry lower clotting risk than oral estrogen. For women with any clotting risk factors, transdermal is frequently the safer choice. Which suits you depends on your history and your preference for daily versus twice-weekly application.

Often within two to four weeks, sometimes sooner — hot flashes and night sweats tend to be among the fastest symptoms to respond. Sleep frequently improves alongside them. Mood, libido, and body composition changes usually take longer, in the range of eight to twelve weeks.

There are still options. Local vaginal estrogen treats dryness and urinary symptoms with minimal systemic absorption and is appropriate for many women who cannot use systemic therapy. Non-hormonal medications for hot flashes are genuinely effective for some women. Vaginal revitalization treatments address tissue comfort without hormones. And treating the adjacent contributors — sleep, thyroid, iron, vitamin D — often helps more than expected.

If you still have a uterus, yes. Unopposed estrogen stimulates the uterine lining and increases the risk of endometrial cancer, so progesterone is included to protect it. Women who have had a hysterectomy typically do not need it. This is standard practice and not something to skip.

There is no single correct duration, and the older advice to stop at an arbitrary point has softened. Duration should be revisited periodically based on your symptoms, your risk profile as you age, and your preferences. Some women use it for a few years through the worst of the transition; others continue longer with ongoing monitoring. It is a decision to revisit, not to make once.